The Efficacy and Safety of Low-Level Tragus Stimulation on Heart Rate Variability, Neutrophil-Lymphocyte Ratio, and Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction (TESLA-STEMI)
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT06537583
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- Universitas Diponegoro
- Registry
-
NCT06537583
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Indonesia
- Registry status
- Unknown status
Technical summary
Registry record NCT06537583. Randomized; single masking; primary purpose treatment. Start 2024-01-01 (actual); primary completion 2024-08-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy and Safety of Low-Level Tragus Stimulation on Heart Rate Variability, Neutrophil-Lymphocyte Ratio, and Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction (TESLA-STEMI)
- Acronym
- TESLA-STEMI
- Condition
- ST Elevation Myocardial Infarction
- Intervention (Device)
- Parasym Neuromodulation Device (Treatment Group)
- Intervention (Device)
- Parasym Neuromodulation Device (Sham Group)
- Lead sponsor
- Universitas Diponegoro
Record details
- Record id
cardio:ct-nct06537583- Content hash
164a41f2125b10800b15cbb4ba8087b906fe0dd69c216c61e9b73baf17a072dd